Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 847 results for "Novartis Company"

Novartis in Rumored Talks to Sell $14 Billion Roche Stake
Pharmaceutical Manufacturing Magazine

Novartis aims for $1 billion in savings from centralization plans

Dive Brief: Novartis CEO Joe Jimenez hopes the Swiss pharma company's new integrated manufacturing plan will save $1 billion by 2020. Speaking on a investor call, Jimenez said the savings would help support margin expansion and free up resources ... BioPharma Dive, 3 days ago
Novartis takes 85% stake in Chinese vaccine firm Manufacturing Chemist, 4 days ago
[x]  

Senior Analyst & Financial Control and Compliance @ Hyderabad

Job Description: Company: Novartis Healthcare Pvt Ltd Position: Senior Analyst Financial Control and Compliance Job Location: Hyderabad Qualification: Chartered Accountant / MBA Finance / ICWA *Job Description The BPC Senior Analyst ...
 Siasat Daily4 days ago

MorphoSys announces its partner Novartis' phase 2b/3 study of bimagrumab in sporadic inclusion body myositis fails to meet primary endpoint

MorphoSys AG, a German biotechnology company, announced that its partner Novartis has confirmed that a phase 2b/3 study examining bimagrumab (BYM338) in sporadic inclusion body myositis (sIBM) did not meet its primary endpoint. Data are currently ...
 PharmaBiz6 days ago Novartis muscular drug fails in Phase III trials  Pharmafile1 week ago
Bloomberg

Novartis Earnings Fall on Slide in Cancer-Drug Sales

By Denise Roland Novartis AG said earnings fell in the first quarter of the year, on a slide in sales of the company's blockbuster cancer drug Gleevec and investment in new drug launches. Basel, Switzerland-based Novartis said net income for the ...
 4 Traders1 week ago GlaxoSmithKline Sees First-Quarter Profit Fall  4 Traders4 days ago Drugs giant GSK reports slump in profits  New Vision4 days ago Novartis income falls as key cancer drug battles generic competition  BioPharma Dive1 week ago
[x]  
Money Today

Sun Pharma gains after acquiring 14 prescription brands from Novartis in Japan

Sun Pharmaceutical Industries rose 1.97% to Rs 809.70 at 9:25 ISt on BSE after the company announced the acquisition of 14 established prescription brands from Novartis AG and Novartis Pharma AG (together Novartis) in Japan.
 Business Standard1 month ago Sun Pharma’s Novartis deal could be a bright spot  Economic Times1 month ago 7 Transactions and Mergers for Concern among Pharmaceutical Companies in 2016 Q1  CPhI.cn1 week ago Sun Pharma up 3% on 14 prescription brands acquisition in Japan  Money Control1 month ago
[x]  
Money Control

Drug firm Novartis launches Scapho for treatment of psoriasis

Scapho or Secukinumab, an injectable medicine, has been approved by the Drug Controller General of India (DCGI), a company statement said here.
 Money Control1 month ago Novartis Healthcare launches psoriasis treatment drug in India  Economic Times1 month ago Novartis: eyes on new launch  Business Line1 month ago

Sun Pharma gains nearly 3% as company buys 14 brands from Novartis

This acquisition marks Sun Pharma's foray into the Japanese prescription market and provides us an opportunity to build a larger product portfolio in the future. Mumbai : Shares of Sun Pharma rose by nearly 3 per cent on March 30 as the drug major forayed ...
 Asian Age1 month ago

Novartis India posts Rs 60 cr net profit

Novartis India today reported a net profit of Rs 59.81 crore for the third quarter ended December 31, 2015. The company had posted a net loss of Rs 1.18 crore in the same period last fiscal, Novartis India said in a BSE filing. Net sales during the period ...
 Business Line2 months ago Novartis India Q3 net at Rs 60 cr  Business Standard2 months ago
Mail.com

Novartis profits dip as generic rival challenges cancer drug

The Basel-based company said Thursday that net income from continuing operations declined to $2.01 billion from $2.31 billion a year earlier. Sales dipped 3 percent to $11.6 billion. Novartis noted the start of sales of a U.S. generic version of ...
 Mail.com1 week ago Novartis profits dip on generic challenge  NEWS.com.au1 week ago Novartis first quarter earnings drop 13pc  Oman Observer1 week ago
[x]  

BL Twenty Years Ago Today: Ciba, Sandoz announce merger to form Novartis

Ciba-Geigy AG and Sandoz AG, Switzerlands two largest Pharmaceuticals companies, said they will merge to form the world's second-largest drug company with estimated sales of 26 billion Swiss francs ($21.8 billions). The companies said in a joint statement ...
 Business Line1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less